|
| Status |
Public on Jul 18, 2024 |
| Title |
SMARCB1 loss defines a novel PTCL-NOS subtype displaying an immunosuppressive TME susceptible to HDAC inhibitors |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
39362842 |
| |
| Submission date |
Dec 06, 2021 |
| Last update date |
Oct 17, 2024 |
| Contact name |
Carolin Walter |
| E-mail(s) |
c_walt03@uni-muenster.de
|
| Organization name |
Westfälische Wilhelms-Universität Münster
|
| Department |
Medical Faculty of the WWU Münster
|
| Lab |
Institute of Medical Informatics
|
| Street address |
Domagkstraße 9
|
| City |
Münster |
| ZIP/Postal code |
48149 |
| Country |
Germany |
| |
|
| Platforms (1) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
| Samples (13)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE190273 |
SMARCB1 loss defines a novel PTCL-NOS subtype displaying an immunosuppressive TME susceptible to HDAC inhibitors [bulk RNA-seq] |
| GSE190274 |
SMARCB1 loss defines a novel PTCL-NOS subtype displaying an immunosuppressive TME susceptible to HDAC inhibitors [single-cell RNA-seq] |
|
| Relations |
| BioProject |
PRJNA786571 |
Less...
More...